2Kobeissy FH, Sadasivan S, Oil MW, et al. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Pmteomics Clin Appl, 2008,2 ( 10-11 ) :1467-1483. 被引量：1
3Shlosberg D, Benifla M, Kaufer D, et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol,2010,6(7) :393-403. 被引量：1
4Zhao J, Moore AN, Redell JB, et al. Enhancing expression of Nrf2- driven genes protects the blood brain barrier after brain injury. J Neuresei ,2007,27 ( 38 ) : 10240-10248. 被引量：1
5Yeung D, Manias JL, Stewart DJ, et al. Decreased junctional adhesion moleeule-A expression during blood-brain barrier breakdown. Aeta Neuropathol,2008,115 ( 6 ) :635-642. 被引量：1
7Lin Z, Han M, Li H, et al. Soluble vascular adhesion protein-l: decreased activity in the plasma of trauma victims andpredictive marker for severity of traumatic brain injury. Clin Chim Acta,2011, 412 ( 17-18 ) : 1678-1682. 被引量：1
8Helmy A,Carpenter KL,Menon DK,et al. The cytokine response to human traumatic brain injury: temporal profiles and evidence forcerebral parenchymal production. J Cereb Blood Flow Metab, 2011,31 (2) :658-670. 被引量：1
9BergerRP, Beers SR, Richiehi R, et al. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma, 2007,24 ( 12 ) : 1793 -1801. 被引量：1
10Piazza O, Storti MP, Cotena S, et al. S100B is not a reliable prognostic index in paediatric TBI. Pediatr Neurosurg,2007,43 (4) : 258-264. 被引量：1
